Literature DB >> 16123129

Interferon function is not required for recovery from a secondary poxvirus infection.

Vijay Panchanathan1, Geeta Chaudhri, Gunasegaran Karupiah.   

Abstract

IFN function is critical for recovery from most primary viral infections, including poxvirus infection. In contrast, very little is known about the requirement for IFN function in mediating recovery from a secondary virus infection. We have used ectromelia virus (ECTV), an orthopoxvirus very closely related to variola virus, to investigate the importance of IFN function in recovery from a secondary infection. Variola virus, the causative agent of smallpox in humans, and ECTV, which causes mousepox in mice, both encode receptor homologs that are thought to interfere with host IFN function. Using a prime-challenge regime, in which avirulent ECTV is used to prime mice deficient in type I/II IFN function or IFN regulatory factor 1 (IRF-1) and then challenging the mice with a virulent strain, we show that IFN function is redundant for virus clearance during a secondary ECTV infection. A neutralizing Ab response is generated in a secondary infection, even in the absence of IFN function, although when present, IFN strongly influences the neutralizing titer and subtype of IgG that is produced. Importantly, the depletion of CD8+ T lymphocytes during a secondary challenge in IFN-deficient mice does not affect their capacity to clear ECTV, indicating that Ab is critical for the control of a secondary infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16123129      PMCID: PMC1200282          DOI: 10.1073/pnas.0505180102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Techniques for studying murine natural killer cells in defense against viral infection.

Authors:  A A Scalzo; H E Farrell; G Karupiah
Journal:  Methods Mol Biol       Date:  2000

Review 2.  Viruses and interferons.

Authors:  G C Sen
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

3.  Overexpression of Bcl-2 differentially restores development of thymus-derived CD4-8+ T cells and intestinal intraepithelial T cells in IFN-regulatory factor-1-deficient mice.

Authors:  T Ohteki; C Maki; S Koyasu
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

4.  Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.

Authors:  Yvette Edghill-Smith; Hana Golding; Jody Manischewitz; Lisa R King; Dorothy Scott; Mike Bray; Aysegul Nalca; Jay W Hooper; Chris A Whitehouse; Joern E Schmitz; Keith A Reimann; Genoveffa Franchini
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

5.  Soluble interferon-gamma receptors encoded by poxviruses.

Authors:  A Alcamí; G L Smith
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1996-09       Impact factor: 2.268

Review 6.  The role of gamma interferon in antimicrobial immunity.

Authors:  R Shtrichman; C E Samuel
Journal:  Curr Opin Microbiol       Date:  2001-06       Impact factor: 7.934

7.  An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model.

Authors:  Mansun Law; Mike M Pütz; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2005-04       Impact factor: 3.891

8.  Inhibition of interferons by ectromelia virus.

Authors:  Vincent P Smith; Antonio Alcami
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.

Authors:  Nathan W Bartlett; Karen Buttigieg; Sergei V Kotenko; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2005-06       Impact factor: 3.891

10.  Impaired IFN-gamma production in IFN regulatory factor-1 knockout mice during endotoxemia is secondary to a loss of both IL-12 and IL-12 receptor expression.

Authors:  C A Salkowski; K E Thomas; M J Cody; S N Vogel
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

View more
  33 in total

1.  Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.

Authors:  Vijay Panchanathan; Geeta Chaudhri; Gunasegaran Karupiah
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection.

Authors:  Isaac G Sakala; Geeta Chaudhri; R Mark Buller; Anthony A Nuara; Hongdong Bai; Nanhai Chen; Gunasegaran Karupiah
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Loss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo.

Authors:  Helena Lynn; Jacquelyn Horsington; Lee Kuan Ter; Shuyi Han; Yee Lian Chew; Russell J Diefenbach; Michael Way; Geeta Chaudhri; Gunasegaran Karupiah; Timothy P Newsome
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 4.  Evolutionary struggles between NK cells and viruses.

Authors:  Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

5.  Viral Replicative Capacity, Antigen Availability via Hematogenous Spread, and High TFH:TFR Ratios Drive Induction of Potent Neutralizing Antibody Responses.

Authors:  Preethi Eldi; Geeta Chaudhri; Stephen L Nutt; Timothy P Newsome; Gunasegaran Karupiah
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

6.  Ectromelia virus accumulates less double-stranded RNA compared to vaccinia virus in BS-C-1 cells.

Authors:  Tiffany R Frey; Michael H Lehmann; Colton M Ryan; Marie C Pizzorno; Gerd Sutter; Adam R Hersperger
Journal:  Virology       Date:  2017-09       Impact factor: 3.616

7.  Characterization of ectromelia virus deficient in EVM036, the homolog of vaccinia virus F13L, and its application for rapid generation of recombinant viruses.

Authors:  Felicia Roscoe; Ren-Huan Xu; Luis J Sigal
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

8.  Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.

Authors:  Jay W Hooper; Anthony M Ferro; Joseph W Golden; Peter Silvera; Jeanne Dudek; Kim Alterson; Max Custer; Bryan Rivers; John Morris; Gary Owens; Jonathan F Smith; Kurt I Kamrud
Journal:  Vaccine       Date:  2009-10-13       Impact factor: 3.641

9.  Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.

Authors:  Pavlo Sakhatskyy; Shixia Wang; Chuanyou Zhang; Te-Hui Chou; Michael Kishko; Shan Lu
Journal:  Virology       Date:  2007-10-24       Impact factor: 3.616

10.  Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice.

Authors:  Henning Lauterbach; Ronny Kassub; Juliane Pätzold; Jana Körner; Michael Brückel; Admar Verschoor; Paul Chaplin; Mark Suter; Hubertus Hochrein
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.